This study aims to examine the biogenic production, characterization, and anti‐acetylcholinesterase (AAChE) properties of polyherbal formulation PHF‐extract‐synthesized silver nanoparticles (PHF‐AgNPs). The Elapidae snake Bungarus sindanus has extremely dangerous venom for humans and contains a high amount of AChE (acetylcholinesterase). Inhibiting AChE leads to acetylcholine buildup, affecting neurotransmission. The study tested silver nanoparticles as AChE inhibitors using kinetics. Their production was confirmed through ultraviolet (UV) spectrometry at 425 nm (SPR peak of 1.94), and stabilizing functional groups were identified via Fourier transform infrared spectroscopy (FT‐IR). The average length of 20 nm was confirmed by analyzing the scanning electron microscopy (SEM) data. Energy‐dispersive X‐ray spectroscopy (EDX) identified silver as the primary component of PHF‐AgNPs (26%). Statistical analysis showed that the activity of AChE in krait venom decreased by up to 45% and 37% at a given dose of ACh (0.5 mM) by PHF and AgNPs, respectively. Utilizing the Lineweaver‐Burk plot for kinetic analysis, a competitive type of inhibition is found.Research Highlights
Successfully synthesized PHF‐extract‐induced silver nanoparticles (PHF‐AgNPs) demonstrated through UV spectrometry and characterized as crystalline with an average size of 45 nm by X‐ray diffraction.
PHF‐AgNPs effectively inhibited acetylcholinesterase (AChE), an enzyme critical in neurotransmission, reducing its activity in krait venom by up to 45% at certain concentrations.
Kinetic analysis revealed that the inhibition mechanism of AChE by PHF‐AgNPs is competitive, offering potential for therapeutic applications in neurologically related conditions.